C13Efficacy in Cancer Versus Non-cancer Patients Treated with Methylnaltrexone: An Analysis of Two Placebo-controlled Studies
Methylnaltrexone (MNTX, Relistor ®) inhibits opioid peripheral adverse effects. This post hoc analysis evaluated pooled data from 2 randomized, double-blind studies and open-label extensions of adults with advanced illness and opioid-induced constipation.
Source: Pain Management Nursing - Category: Nursing Authors: Michelle Rhiner Source Type: research
More News: Cancer | Cancer & Oncology | Constipation | Nurses | Nursing | Pain | Pain Management | Study